Sales revenues for December 2021
Sofia, Bulgaria, January 10, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for December 2021 the Company recorded a decrease in sales of 4% compared to the same month of the previous year, incl. 32% decrease in domestic sales and 19% increase in export sales.
Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
Sofia, Bulgaria, January 6, 2022 – According to the requirements of Art. 100t of LPOS and in connection with Art. 114, para. 9 of the Law on Public Offering of Securities, “Sopharma” AD announces that today, according to a decision of the Board of Directors dated December 21, 2021, the company concluded the following transactions falling within the scope of Art. 114, para. 2 of the LPOS:
- 1. “Sopharma” AD as a BUYER concluded a Contract for purchase and sale of 13 (thirteen) motor vehicles, owned by “Telecomplect” AD, UIC 831643753.
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 30 December 2021.
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 30 December 2021.
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 23 December 2021.
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 23 December 2021.
The subscription for the public offering of warrants is successfully completed
Sofia, Bulgaria, December 30, 2021 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that the subscription for the public offering of the warrants of the Company has been successfully completed.
The results of the public offering are as follows:
Sale of the share in the capital of the subsidiary SIA „Briz“
София, България, 23 декември 2021 година – Съгласно изискванията на чл. 100т от ЗППЦК, “Софарма“ АД уведомява, че на свое заседание Съветът на директорите прие решение за разпореждане с всички притежавани от Дружеството дялове (100%) в капитала на СИА „Бриз“ (SIA Briz), Латвия. Решението е в изпълнение на стратегията на Дружеството за оптимизиране на търговската дейност, по-добро представяне на всички пазари и увеличаване на добавената стойност за акционерите.